证券记录 · 已归档季度
ZBH
Zimmer Biomet Holdings, Inc. · Healthcare · Medical - Devices
16被追踪持有人
-2Δ持有人
46.04M持有股份
$4.97B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -11.1% ·
股份流向 +3.8% ·
净新建仓位 -12.5%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | +1 | 160.28M | $13.80B | +8 | −6 |
| Q1 2026 | 159 | -2 | 157.26M | $14.21B | +8 | −11 |
| Q4 2025 | 160 | -1 | 174.74M | $15.72B | +3 | −3 |
| Q3 2025 | 25 | +3 | 107.43M | $10.58B | +3 | −1 |
| Q2 2025 | 20 | -3 | 103.64M | $9.45B | +2 | −5 |
| Q1 2025 | 20 | +3 | 59.00M | $6.68B | +3 | — |
| Q4 2024 | 17 | 0 | 58.85M | $6.22B | +1 | −1 |
| Q3 2024 | 16 | -2 | 46.04M | $4.97B | — | −2 |
| Q2 2024 | 18 | — | 44.34M | $4.81B | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 17.07M | +2.0% | $1.84B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 14.58M | +16.6% | $1.57B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 14.58M | +16.6% | $1.57B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 4 | PRIMECAP Management ✦ | 4.97M | -1.6% | $536.66M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 4.88M | +2.6% | $524.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 4.88M | +2.6% | $524.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Norges Bank ✦ (被动) | 1.91M | -13.6% | $206.17M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 569.59K | -12.2% | $61.49M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 484.78K | +28.8% | $52.33M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 484.78K | +28.8% | $52.33M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 421.80K | +0.2% | $45.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 421.80K | +0.2% | $45.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 421.80K | +0.2% | $45.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 421.80K | +0.2% | $45.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 370.01K | -24.5% | $39.94M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 213.33K | -0.9% | $23.03M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 180.63K | -48.6% | $19.50M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Millennium Management ✦ | 175.44K | -20.4% | $18.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 153.30K | -15.3% | $16.55M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Wellington Management ✦ | 37.07K | +12.3% | $4.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Wellington Management ✦ | 37.07K | +12.3% | $4.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 10.44K | -84.9% | $1.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 4.90K | -6.3% | $529,050 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Marshall Wace | $6.08M | 曾为 0.0% |
| Capital World Investors | $300,411 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 908 持有人, 191.49M 股份, $15.84B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据